2018 Pharma Choice Unbranded Bronze Winner NAVICOR and Celgene Corporation

NAVICOR

Celgene Corporation

Celgene “Chemosaurus”

Chemotherapy, a backbone of indolent non-Hodgkin’s lymphoma therapy for more than 50 years, has not evolved to match recent improved understanding of iNHL. Celgene is focused on therapies that allow cancer patients to thrive during treatment, virtually rendering chemotherapy extinct.

Agency Team:

Managing Director, Executive Creative Director: Marvin J. Bowe, III
VP, Creative Director: James A. Griffith II
ACD, Copy: Tom Ferrara
ACD, Art: Ana Ferreira
Sr. Art Director: John Catania
Sr. Art Director: Monica Ibarra
Design & Fabrication Firm: Creative Machines
CGI Artist: Taylor James

Ads

You May Also Like

Which GDPR Strategy Paid Off?

In the lead up to the EU General Data Protection Regulation (GDPR), marketers speculated ...

PM360 2019 Innovative Division Valuate Health Consultancy of Omnicom Health Group

Valuate Health Consultancy Omnicom Health Group Dina Steinfurth, Managing Director dsteinfurth@valuatehealth.com Valuate Health Consultancy ...

How Pharma Can Help Ease the Growing Burden on Healthcare Professionals

Reaching, engaging, and educating physicians is often a pharma marketer’s main task. After all, ...